Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
- DOI
- 10.1111/cen.13003
- Published
- 2016 Jun
- Container
- Clinical endocrinology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cen.13003,
title = {Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.},
author = {Samimi M and Jamilian M and Ebrahimi FA and Rahimi M and Tajbakhsh B and Asemi Z},
year = {2016},
journal = {Clinical endocrinology},
doi = {10.1111/cen.13003},
url = {https://doi.org/10.1111/cen.13003}
}RIS
TY - JOUR TI - Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. AU - Samimi M AU - Jamilian M AU - Ebrahimi FA AU - Rahimi M AU - Tajbakhsh B AU - Asemi Z PY - 2016 JO - Clinical endocrinology DO - 10.1111/cen.13003 UR - https://doi.org/10.1111/cen.13003 ER -
APA
M, S., M, J., FA, E., M, R., B, T., & Z, A. (2016). Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.. Clinical endocrinology. https://doi.org/10.1111/cen.13003
Source records
- pubmed · retrieved 2026-09-24T19:45:28.085Z